These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The pharmacologic approach to airway clearance: mucoactive agents. Rubin BK Respir Care; 2002 Jul; 47(7):818-22. PubMed ID: 12088552 [TBL] [Abstract][Full Text] [Related]
5. Aerosol Medications for Treatment of Mucus Clearance Disorders. Rubin BK Respir Care; 2015 Jun; 60(6):825-9; discussion 830-32. PubMed ID: 26070577 [TBL] [Abstract][Full Text] [Related]
6. The role of mucus in cough research. Rubin BK Lung; 2010 Jan; 188 Suppl 1():S69-72. PubMed ID: 19936981 [TBL] [Abstract][Full Text] [Related]
7. Mucus-controlling agents: past and present. King M; Rubin BK Respir Care Clin N Am; 1999 Dec; 5(4):575-94. PubMed ID: 10565882 [TBL] [Abstract][Full Text] [Related]
8. Mucolytics, expectorants, and mucokinetic medications. Rubin BK Respir Care; 2007 Jul; 52(7):859-65. PubMed ID: 17594730 [TBL] [Abstract][Full Text] [Related]
9. The pharmacologic approach to airway clearance: mucoactive agents. Rubin BK Paediatr Respir Rev; 2006; 7 Suppl 1():S215-9. PubMed ID: 16798570 [TBL] [Abstract][Full Text] [Related]
10. Structure and function of the polymeric mucins in airways mucus. Thornton DJ; Rousseau K; McGuckin MA Annu Rev Physiol; 2008; 70():459-86. PubMed ID: 17850213 [TBL] [Abstract][Full Text] [Related]
11. Drug effects on viscoelasticity of mucus. Puchelle E; Zahm JM; Polu JM; Sadoul P Eur J Respir Dis Suppl; 1980; 110():195-208. PubMed ID: 6938383 [No Abstract] [Full Text] [Related]
12. Pharmacotherapy of impaired mucociliary clearance in non-CF pediatric lung disease. A review of the literature. Boogaard R; de Jongste JC; Merkus PJ Pediatr Pulmonol; 2007 Nov; 42(11):989-1001. PubMed ID: 17902149 [TBL] [Abstract][Full Text] [Related]
13. Mucus structure and properties in cystic fibrosis. Rubin BK Paediatr Respir Rev; 2007 Mar; 8(1):4-7. PubMed ID: 17419972 [TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of new therapies for treatment of mucus hypersecretion in respiratory diseases. Disse B Novartis Found Symp; 2002; 248():254-72; discussion 272-6, 277-82. PubMed ID: 12568499 [TBL] [Abstract][Full Text] [Related]
17. Effects of seaprose on the rheology of bronchial mucus in patients with chronic bronchitis. A double-blind study vs placebo. Braga PC; Moretti M; Piacenza A; Montoli CC; Guffanti EE Int J Clin Pharmacol Res; 1993; 13(3):179-85. PubMed ID: 8225701 [TBL] [Abstract][Full Text] [Related]
18. Rheological profile of nesosteine: a new mucoactive agent. Braga PC; Beghi G; Castelli C; Grasselli G; Ornaghi A; Rampoldi C; Zheng Y; Allegra L Int J Clin Pharmacol Res; 1989; 9(1):77-83. PubMed ID: 2707929 [TBL] [Abstract][Full Text] [Related]
20. [Mucolytics in acute and chronic respiratory tract disorders. I. Pathophysiology and mechanisms of action]. Kupczyk M; Kuna P Pol Merkur Lekarski; 2002 Mar; 12(69):245-7. PubMed ID: 12053600 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]